Calls for papers
-
California-based InCarda Therapeutics (formerly Pleiades Cardio-Therapeutics) has announced that it raised over $5 million with the possibility of an additional $1.5 million in a private financing round led by Morningside Venture. According to the company,… Read more . . .
-
Inhalation Sciences AB (ISAB) has announced that the 3D module of its PreciseInhale dry powder aerosol testing system is now called “XposeALI.” Using air liquid interface (ALI) technology, ISAB creates 3D models with primary epithelial… Read more . . .
-
ASTM International’s Subcommittee on Characterization and Handling of Powders and Bulk Solids has published a new standard titled “Standard Test Method for Shear Testing of Powders using the Freeman Technology FT4 Powder Rheometer Shear Cell.”… Read more . . .
-
Submit full 3-4 page abstracts by 26 July at http://www.ddl-conference.org.uk/?q=abstractsubmissionDDL26. Abstract guidelines can be found at http://www.ddl-conference.org.uk/?q=ddl-abstract-guidelines2015 Read more . . .
-
According to Copley Scientific, the company will display several new cascade impactor testing accessories at the upcoming RDD Europe meeting in Antibes, France. The new products include a set of interchangeable quick-release attachments for the… Read more . . .
-
The International Society of Aerosol Medicine (ISAM) has resumed accepting poster abstracts for the 2015 ISAM Congress, to be held May 30-June 3, organizers have announced. Topics include Pediatrics & CF, Regulatory & Standardization, New… Read more . . .
-
Inhaled drug developer Aradigm has announced the appointment of Robert A. Reed as VP, Regulatory (CMC) and Quality. Reed was most recently Senior VP of CMC and Technical Operations at Celsion Corporation and has also… Read more . . .
-
According to Mylan, the United States Court of Appeals for the Federal Circuit has affirmed a lower court’s March 2014 decision upholding the validity of four Mylan patents related to Perforomist formoterol fumarate inhalation solution… Read more . . .
-
Adamis Pharmaceuticals has announced that a clinical study comparing its APC-2000 albuterol MDI with GSK’s Ventolin Evohaler MDI met its primary endpoint, showing equivalence in change from baseline of FEV1 for both doses tested (100… Read more . . .
-
AstraZeneca announced that it has entered into a five-year partnership agreement with patient network PatientsLikeMe for access to patient-reported data in several treatment areas, including respiratory. PatientsLikeMe offers a program called “data for good,” whose… Read more . . .
Upcoming Events
Sponsored by Intertek
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
December 9-December 11: DDL 2026, Edinburgh, Scotland
April 27-30: RDD Europe 2027, Antibes, France
May 12-13: USP Joint Workshop: Quality and Product Performance Testing of Orally Inhaled and Nasal Drug Products, Rockville, MD, USA
June 30: RespireX 2027, Boston, MA, USA